The Danish pharmaceutical company Novo Nordisk has seen its shares decline by nearly 50 per cent over the past year, following a warning of a significant drop in profits and
The Danish pharmaceutical company Novo Nordisk has seen its shares decline by nearly 50 per cent over the past year, following a warning of a significant drop in profits and






